Friday 6 November 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024.

Revenue: +5.86%
EPS: −95.8%
Free cash flow: −21.4%
Total debt: −9.16%

Quarter to September 2026, against a year earlier

272.44 3.88 −1.40%

Follow JNJ

Alert me

Market cap: $655.6B
P/E: 41.3×
Fwd P/E: 40.0×
Dividend yield: 1.94%
F-score: 3/9
Altman Z: 4.78
Beneish M: −2.26
Dividend safety: 78/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Johnson & Johnson (JNJ) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Johnson & Johnson (JNJ) trades at a P/S ratio of 6.6×. Over the past ten years it has ranged from 3.5× (August 2015) to 6.8× (September 2026); the current reading is higher than 99% of that period. That is above the Drug Manufacturers General industry median of 3.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/JNJ/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Johnson &amp; Johnson P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/JNJ/metrics/ps-ratio">Johnson &amp; Johnson (JNJ) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	5.3×	34.94%
FY2024	3.9×	(17.64%)
FY2023	4.8×	(18.62%)
FY2022	5.8×	2.26%
FY2021	5.7×	13.98%
FY2020	5.0×	6.71%
FY2019	4.7×	10.85%
FY2018	4.2×	(13.48%)
FY2017	4.9×	11.15%
FY2016	4.4×	8.56%

Period	P/S ratio	Change
Sep 2026	6.4×	2.86%
Jun 2026	6.2×	2.18%
Mar 2026	6.1×	15.52%
Dec 2025	5.3×	9.15%
43 more quarters	Free account

Against its own ten years

Low 3.5× High 6.8×

Ten-year median 4.7×

Current reading's percentile 99

Company	P/S ratio
PFE Pfizer Inc. compare	2.7×
AZN AstraZeneca PLC compare	4.7×
NVS Novartis AG compare	5.4×
MRK Merck & Co., Inc. compare	5.4×
AMGN Amgen Inc. compare	6.4×
JNJ Johnson & Johnson	6.6×
GILD Gilead Sciences, Inc. compare	6.7×
ABBV AbbVie Inc. compare	7.7×
LLY Eli Lilly and Company compare	14.1×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Johnson & Johnson (JNJ) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on JNJ

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on JNJ

Stockrow Weekly